Santen Pharmaceutical Co., Ltd. (SNPHF)
USD 9.8
(-21.35%)
USD 9.8
(-21.35%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 435.69 Billion JPY | 3.45% |
| 2023 | 421.17 Billion JPY | -8.43% |
| 2022 | 459.97 Billion JPY | 14.32% |
| 2021 | 402.35 Billion JPY | -1.57% |
| 2020 | 408.76 Billion JPY | 4.49% |
| 2019 | 391.18 Billion JPY | 0.7% |
| 2018 | 388.46 Billion JPY | 20.35% |
| 2017 | 322.77 Billion JPY | -9.18% |
| 2016 | 355.39 Billion JPY | 16.83% |
| 2015 | 304.2 Billion JPY | 31.63% |
| 2014 | 231.1 Billion JPY | 15.76% |
| 2013 | 199.63 Billion JPY | 0.42% |
| 2012 | 198.8 Billion JPY | 7.58% |
| 2011 | 184.8 Billion JPY | 10.74% |
| 2010 | 166.87 Billion JPY | 10.51% |
| 2009 | 151.01 Billion JPY | -3.54% |
| 2008 | 156.54 Billion JPY | -1.6% |
| 2007 | 159.09 Billion JPY | 5.74% |
| 2006 | 150.45 Billion JPY | 7.49% |
| 2005 | 139.97 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 416.52 Billion JPY | -1.1% |
| 2024 Q4 | 435.69 Billion JPY | 1.84% |
| 2024 FY | 435.69 Billion JPY | 3.45% |
| 2024 Q3 | 427.82 Billion JPY | 0.2% |
| 2024 Q2 | 426.98 Billion JPY | 2.51% |
| 2023 Q3 | 420.14 Billion JPY | -1.51% |
| 2023 Q2 | 426.58 Billion JPY | -7.52% |
| 2023 FY | 421.17 Billion JPY | -8.43% |
| 2023 Q4 | 421.17 Billion JPY | 0.25% |
| 2023 Q1 | 461.28 Billion JPY | 0.28% |
| 2022 Q3 | 429.59 Billion JPY | 2.18% |
| 2022 Q1 | 397.09 Billion JPY | -1.31% |
| 2022 Q2 | 420.43 Billion JPY | 5.88% |
| 2022 Q4 | 459.97 Billion JPY | 7.07% |
| 2022 FY | 459.97 Billion JPY | 14.32% |
| 2021 FY | 402.35 Billion JPY | -1.57% |
| 2021 Q1 | 409.58 Billion JPY | 0.2% |
| 2021 Q2 | 420.02 Billion JPY | 2.55% |
| 2021 Q3 | 413.08 Billion JPY | -1.65% |
| 2021 Q4 | 402.35 Billion JPY | -2.6% |
| 2020 Q3 | 407.71 Billion JPY | 2.68% |
| 2020 Q2 | 397.07 Billion JPY | 2.79% |
| 2020 FY | 408.76 Billion JPY | 4.49% |
| 2020 Q1 | 386.3 Billion JPY | -1.25% |
| 2020 Q4 | 408.76 Billion JPY | 0.26% |
| 2019 Q2 | 400.03 Billion JPY | 5.71% |
| 2019 Q4 | 391.18 Billion JPY | 0.75% |
| 2019 Q3 | 388.28 Billion JPY | -2.94% |
| 2019 FY | 391.18 Billion JPY | 0.7% |
| 2019 Q1 | 378.42 Billion JPY | -2.59% |
| 2018 Q2 | 374.18 Billion JPY | 14.93% |
| 2018 FY | 388.46 Billion JPY | 20.35% |
| 2018 Q4 | 388.46 Billion JPY | 2.67% |
| 2018 Q3 | 378.37 Billion JPY | 1.12% |
| 2018 Q1 | 325.57 Billion JPY | 0.87% |
| 2017 Q1 | 328.78 Billion JPY | -7.49% |
| 2017 FY | 322.77 Billion JPY | -9.18% |
| 2017 Q4 | 322.77 Billion JPY | 0.48% |
| 2017 Q3 | 321.24 Billion JPY | -0.71% |
| 2017 Q2 | 323.55 Billion JPY | -1.59% |
| 2016 Q2 | 352.08 Billion JPY | 16.8% |
| 2016 Q1 | 301.44 Billion JPY | -0.9% |
| 2016 FY | 355.39 Billion JPY | 16.83% |
| 2016 Q4 | 355.39 Billion JPY | -1.24% |
| 2016 Q3 | 359.84 Billion JPY | 2.21% |
| 2015 Q3 | 278.01 Billion JPY | 6.26% |
| 2015 Q4 | 304.2 Billion JPY | 9.42% |
| 2015 FY | 304.2 Billion JPY | 31.63% |
| 2015 Q1 | 256.5 Billion JPY | 10.99% |
| 2015 Q2 | 261.63 Billion JPY | 2.0% |
| 2014 FY | 231.1 Billion JPY | 15.76% |
| 2014 Q4 | 231.1 Billion JPY | 5.65% |
| 2014 Q3 | 218.74 Billion JPY | 3.33% |
| 2014 Q2 | 211.68 Billion JPY | 4.0% |
| 2014 Q1 | 203.55 Billion JPY | 1.96% |
| 2013 FY | 199.63 Billion JPY | 0.42% |
| 2013 Q4 | 199.63 Billion JPY | 8.14% |
| 2013 Q2 | 184.74 Billion JPY | -2.19% |
| 2013 Q3 | 184.61 Billion JPY | -0.07% |
| 2013 Q1 | 188.88 Billion JPY | -4.99% |
| 2012 Q4 | 198.8 Billion JPY | 5.98% |
| 2012 Q3 | 187.57 Billion JPY | -0.47% |
| 2012 Q2 | 188.45 Billion JPY | 3.54% |
| 2012 Q1 | 182 Billion JPY | -1.51% |
| 2012 FY | 198.8 Billion JPY | 7.58% |
| 2011 Q3 | 166.16 Billion JPY | -0.72% |
| 2011 FY | 184.8 Billion JPY | 10.74% |
| 2011 Q1 | 159.81 Billion JPY | -4.24% |
| 2011 Q2 | 167.37 Billion JPY | 4.74% |
| 2011 Q4 | 184.8 Billion JPY | 11.21% |
| 2010 Q3 | 161.5 Billion JPY | -1.83% |
| 2010 FY | 166.87 Billion JPY | 10.51% |
| 2010 Q2 | 164.52 Billion JPY | 0.0% |
| 2010 Q4 | 166.87 Billion JPY | 3.33% |
| 2009 Q4 | 151.01 Billion JPY | 0.0% |
| 2009 FY | 151.01 Billion JPY | -3.54% |
| 2008 FY | 156.54 Billion JPY | -1.6% |
| 2007 FY | 159.09 Billion JPY | 5.74% |
| 2006 FY | 150.45 Billion JPY | 7.49% |
| 2005 FY | 139.97 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AstraZeneca PLC | 100.97 Billion USD | -331.487% |
| Bristol-Myers Squibb Company PFD CONV 2 | 95.15 Billion USD | -357.864% |
| CSPC Pharmaceutical Group Limited | 6.52 Billion USD | -6578.389% |
| Clarus Therapeutics Holdings, Inc. | 51.7 Million USD | -842514.296% |
| Novartis AG | 99.94 Billion USD | -335.939% |
| PT Kalbe Farma Tbk. | 1.75 Billion USD | -24673.333% |